Physician

Christopher Emil Haberman, M.D.

According to 2025 Medicare claims, Christopher Haberman, M.D. (NPI: 1750590931) practices hematology/oncology in the Panama City-Panama City Beach, FL market, with the plurality of this provider's patient population coming from Bay, FL. This provider's primary affiliated billing organization is OCALA ONCOLOGY CENTER PL (NPI: 1356300958; TIN: 900336929) and primary practice location at 32405-4587. Haberman is affiliated with the Primary Care Alliance, LLC (ACO ID: D0010), participating under the REACH model.

Haberman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 778 traditional Medicare patients, billed 297,253 HCPCS/CPT codes, and received $4,345,977 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 996 prescription claims across 210 beneficiaries totaling $3,094,977 in drug costs, led by Revlimid (Lenalidomide). DME data shows 38 claims. Open Payments data shows 170 records totaling $3,438. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $1,496,790 and ending at $4,345,977. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $2,621,286 and ending at $3,094,977. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $14,553 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	705	139,626	$1,496,790
2016	702	190,601	$2,226,248
2017	698	162,739	$2,165,427
2018	711	152,153	$1,731,974
2019	661	17,772	$280,871
2020	476	55,268	$539,117
2021	429	121,507	$1,653,191
2022	610	217,409	$3,304,053
2023	776	259,874	$3,384,847
2024	778	297,253	$4,345,977

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	290	2,063	$2,621,286
2016	321	2,141	$2,689,604
2017	323	2,189	$2,104,786
2018	330	2,019	$2,679,789
2019	339	1,933	$2,845,168
2020	240	837	$1,348,575
2021	141	537	$968,964
2022	152	772	$2,385,798
2023	205	956	$3,558,174
2024	210	996	$3,094,977

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	42	233	$60,917
2016	N/R	67	$6,732
2017	N/R	31	$3,187
2018	N/R	23	$4,771
2019	N/R	96	$10,384
2020	N/R	74	$7,844
2021	N/R	55	$5,832
2022	N/R	34	$3,335
2023	N/R	56	$5,208
2024	N/R	38	$4,574

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	381	723	$100
80053	Blood test, comprehensive group of blood chemicals	437	1,613	$10
36415	Insertion of needle into vein for collection of blood sample	508	2,009	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	515	2,507	$8
83540	Iron level	210	374	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	17	476	$287,785
Lenalidomide	Lenalidomide	20	553	$285,625
Lenvima	Lenvatinib Mesylate	11	330	$268,147
Imbruvica	Ibrutinib	16	448	$260,954
Brukinsa	Zanubrutinib	17	510	$252,869

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
B4152	Enteral formula, nutritionally complete, calorically dense (equal to or greater than 1.5 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit	N	N/R	19	$3,087
B4034	Enteral feeding supply kit; syringe fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape	N	N/R	19	$1,487

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	170	$3,438	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Christopher Emil Haberman, M.D.?

Tedicare shows public-source Medicare data for Christopher Emil Haberman, M.D. (NPI 1750590931), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Christopher Emil Haberman, M.D. have ACO affiliation data?

Christopher Emil Haberman, M.D. is shown with ACO affiliation data for Primary Care Alliance, LLC (REACH, ACO ID D0010).

What billing organization is linked to Christopher Emil Haberman, M.D.?

Christopher Emil Haberman, M.D. is linked to OCALA ONCOLOGY CENTER PL (billing NPI 1356300958) in the available physician profile data.

Does Christopher Emil Haberman, M.D. have Open Payments data?

Christopher Emil Haberman, M.D. has 170 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.